BGI Genomics Co., Ltd.

300676

CNE100003449

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-07-16 EDT			5-day change	1st Jan Change
35.44 ^CNY	+0.40%		+1.87%	-26.17%

06-27	BGI Genomics Co., Ltd. Announces Final Cash Dividend Plan on A Shares for the Year 2023, Payable on 4 July 2024	CI
06-19	BGI Genomics Co., Ltd. Announces Board Appointments	CI

Beijing Gene+ Technology announced that it has received CNY 50 million in funding from BGI Genomics Co., Ltd.

January 09, 2019

On January 10, 2019, Beijing Gene+ Technology closed the transaction. The company has completed the change of business registration.

Latest news about BGI Genomics Co., Ltd.

BGI Genomics Co., Ltd. Announces Final Cash Dividend Plan on A Shares for the Year 2023, Payable on 4 July 2024	06-27	CI
BGI Genomics Co., Ltd. Announces Board Appointments	06-19	CI
US Legislation Banning Chinese Biotech Firms Will Suppress Legislation, BGI Says	05-20	MT
Bgi Genomics Co., Ltd. Approves Cash Dividend for 2023	05-10	CI
BGI Genomics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
BGI Genomics Co., Ltd. Proposes Final Cash Dividend for the Year 2023	04-15	CI
BGI Genomics' 2023 Profit Falls 89% as Revenue Plunges 38%	02-29	MT
BGI Genomics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
China stocks rise further on market rescue hopes; HK flat	02-06	RE
Wuxi AppTec Denies Ties to Military in Wake of US Draft Bill Targeting Chinese Biotech Firms	02-05	MT
US bill targeting Chinese biotech firms WuXi AppTec, BGI hits delay	02-02	RE
Correction: GemPharmatech Responds to US Legislation Concerns	01-29	MT
Correction: Chinese Shares End Lower on US Draft Bill Targeting Chinese Biotech Firms; MGI Slumps 12%, Wuxi AppTec Falls 9%	01-29	MT
GemPharmatech Responds to US Legislation Concerns	01-29	MT
MGI Tech Responds to US BIOSECURE Act	01-29	MT
Chinese Shares End Lower on US Draft Bill Targeting Chinese Biotech Firms; MGI Slumps 12%, Wuxi AppTec Falls 9%	01-29	MT
US House bill would curb genetic info sharing with China's Wuxi Apptec, BGI	01-26	RE
BGI Genomics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Chinese Shares Extend Losses as Bank Borrowing Plunges to 14-Year Low; BGI Falls 6% After M&A Announcement	23-08-14	MT
BGI Genomics to Acquire Health Management Firm; Shares Slump 6%	23-08-14	MT
BGI Genomics Co., Ltd. signed a share transfer agreement to acquire Shenzhen Huada Special Inspection Technology Co., Ltd. from Shenzhen BGI Hospital Management Holding Co., Ltd. for CNY 0.71 million.	23-08-11	CI
BGI Genomics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-11	CI
BGI Genomics Appoints COO	23-06-30	MT
Bgi Genomics Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 7 June 2023	23-05-31	CI
Bgi Genomics Co., Ltd. Approves Cash Dividend for 2022	23-05-10	CI

BGI Genomics Co., Ltd. is a leading provider of genomic and proteomic sequencing services primarily to academic institutions, pharmaceutical companies and healthcare providers. The company also provides genomic solutions for biomarker research and development, screening for some of the trisomies present at birth (trisomy 21, trisomy 18 and trisomy 13) and solutions for neo-antigen identification for immuno-oncology research.

Sector

Biotechnology & Medical Research

Calendar

2024-08-23 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
BGI GENOMICS CO., LTD.	-26.17%	1.85B
EXACT SCIENCES CORPORATION	-33.27%	9.17B
GUARDANT HEALTH, INC.	+20.33%	4.14B
IOVANCE BIOTHERAPEUTICS, INC.	+9.96%	2.63B
VERACYTE, INC.	-8.11%	1.95B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+41.83%	1.22B
CAREDX, INC	+52.50%	969M
SEEGENE, INC.	-6.77%	694M
CURIOX BIOSYSTEMS CO., LTD	-18.99%	235M
HLB BIOSTEP CO.,LTD.	-12.78%	168M

Bio Diagnostics & Testing

BGI Genomics Co., Ltd.

Equities

300676

CNE100003449

Biotechnology & Medical Research

Beijing Gene+ Technology announced that it has received CNY 50 million in funding from BGI Genomics Co., Ltd.

Latest news about BGI Genomics Co., Ltd.

Chart BGI Genomics Co., Ltd.

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Bio Diagnostics & Testing